» Articles » PMID: 28608737

Preoperative F-FDG-PET/CT Vs Contrast-Enhanced CT to Identify Regional Nodal Metastasis Among Patients with Head and Neck Squamous Cell Carcinoma

Abstract

Objective Our objective was to compare the accuracy of preoperative positron emission tomography (PET)/computed tomography (CT) and contrast-enhanced CT (CECT) in detecting cervical nodal metastases in patients treated with neck dissection and to scrutinize the ability of each modality to determine nodal stage. Study Design Case series with chart review. Setting Montefiore Medical Center, Bronx, New York. Subjects and Methods Patients who underwent neck dissection at our institution for primary treatment of head and neck squamous cell carcinoma (HNSCC) and had received preoperative PET/CT and CECT were included in this study. Imaging studies were reinterpreted by 3 specialists within the field and compared for interreader agreement. Concordance between radiology and histopathology was measured using neck levels and sides, along with patient nodal stage. Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and agreement coefficients were calculated. Results Seventy-three patients were included in the study. Sensitivity was 0.69 and 0.94 (level and side) for PET/CT vs 0.53 and 0.66 for CECT ( P = .056, P = .001). Specificity was 0.86 and 0.56 for PET/CT vs 0.91 and 0.76 for CECT ( P = .014, P = .024). No significant difference was found in overall accuracy ( P = .33, P = .88). The overall agreement percentages between N stage called by imaging modality and pathology were 52% and 55% for PET/CT and CECT, respectively. Conclusion No significant difference in sensitivity was found between PET/CT and CECT. CECT was found to have superior specificity compared with PET/CT. The information gleaned from each modality in the pretreatment evaluation of HNSCC appears to be complementary.

Citing Articles

Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies.

Asarkar A, Chang B, de Bree R, Kowalski L, Guntinas-Lichius O, Bradley P Adv Ther. 2024; 41(6):2133-2150.

PMID: 38642199 DOI: 10.1007/s12325-024-02861-6.


Using quantitative parameters derived from pretreatment dual-energy computed tomography to predict histopathologic features in head and neck squamous cell carcinoma.

Shen H, Huang Y, Yuan X, Liu D, Tu C, Wang Y Quant Imaging Med Surg. 2022; 12(2):1243-1256.

PMID: 35111620 PMC: 8739140. DOI: 10.21037/qims-21-650.


Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [F]FDG PET/CT and MRI.

Linz C, Brands R, Kertels O, Dierks A, Brumberg J, Gerhard-Hartmann E Eur J Nucl Med Mol Imaging. 2021; 48(12):3951-3960.

PMID: 34050405 PMC: 8484183. DOI: 10.1007/s00259-021-05422-z.


Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.

Linz C, Brands R, Herterich T, Hartmann S, Muller-Richter U, Kubler A JAMA Netw Open. 2021; 4(4):e217083.

PMID: 33881529 PMC: 8060833. DOI: 10.1001/jamanetworkopen.2021.7083.


Prognostic value of F-FDG PET/CT parameters and histopathologic variables in head and neck cancer.

Aslan H, Cekin G, Pinar E, Yazir M, Imre A, Songu M Braz J Otorhinolaryngol. 2020; 87(4):452-456.

PMID: 31899125 PMC: 9422361. DOI: 10.1016/j.bjorl.2019.10.014.


References
1.
Som P, Curtin H, Mancuso A . An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999; 125(4):388-96. DOI: 10.1001/archotol.125.4.388. View

2.
Pitman K . Rationale for elective neck dissection. Am J Otolaryngol. 2000; 21(1):31-7. DOI: 10.1016/s0196-0709(00)80121-0. View

3.
Weber A, Romo L, Hashmi S . Malignant tumors of the oral cavity and oropharynx: clinical, pathologic, and radiologic evaluation. Neuroimaging Clin N Am. 2003; 13(3):443-64. DOI: 10.1016/s1052-5149(03)00037-6. View

4.
Fukui M, Blodgett T, Snyderman C, Johnson J, Myers E, Townsend D . Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics. 2005; 25(4):913-30. DOI: 10.1148/rg.254045136. View

5.
Snow G, Patel P, Leemans C, Tiwari R . Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 1992; 249(4):187-94. DOI: 10.1007/BF00178467. View